632 related articles for article (PubMed ID: 8968549)
1. Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.
Hills DM; Gerskowitch VP; Roberts SP; Welsh NJ; Shankley NP; Black JW
Br J Pharmacol; 1996 Dec; 119(7):1401-10. PubMed ID: 8968549
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.
Roberts SP; Harper EA; Watt GF; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1996 Aug; 118(7):1779-89. PubMed ID: 8842444
[TBL] [Abstract][Full Text] [Related]
3. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
Yuki H; Nishida A; Miyake A; Ito H; Akuzawa S; Takinami Y; Takemoto Y; Miyata K
Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
Bertrand P; Böhme GA; Durieux C; Guyon C; Capet M; Jeantaud B; Boudeau P; Ducos B; Pendley CE; Martin GE
Eur J Pharmacol; 1994 Sep; 262(3):233-45. PubMed ID: 7813588
[TBL] [Abstract][Full Text] [Related]
5. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
[TBL] [Abstract][Full Text] [Related]
6. Selective action of a CCK-B/gastrin receptor antagonist, S-0509, on pentagastrin-, peptone meal- and beer-stimulated gastric acid secretion in dogs.
Sasaki N; Matsuno K; Okabe S
Aliment Pharmacol Ther; 2000 Apr; 14(4):479-88. PubMed ID: 10759628
[TBL] [Abstract][Full Text] [Related]
7. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN
Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach.
Black JW; Leff P; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):589-99. PubMed ID: 2866003
[TBL] [Abstract][Full Text] [Related]
9. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Nagaya H; Inatomi N; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
[TBL] [Abstract][Full Text] [Related]
10. Effects of S-0509, a novel CCKB/gastrin receptor antagonist, on acid secretion and experimental duodenal ulcers in rats.
Takeuchi K; Hirata T; Yamamoto H; Kunikata T; Ishikawa M; Ishihara Y
Aliment Pharmacol Ther; 1999 Jan; 13(1):87-96. PubMed ID: 9892884
[TBL] [Abstract][Full Text] [Related]
11. Histamine dependence of pentagastrin-stimulated gastric acid secretion in rats.
Shankley NP; Welsh NJ; Black JW
Yale J Biol Med; 1992; 65(6):613-9. PubMed ID: 1285198
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
Takeda M; Takagi T; Maeno H
Eur J Pharmacol; 1983 Aug; 91(4):371-6. PubMed ID: 6137398
[TBL] [Abstract][Full Text] [Related]
14. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
Ding XQ; Lindström E; Håkanson R
Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
[TBL] [Abstract][Full Text] [Related]
15. Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum.
Patel M; Spraggs CF
Br J Pharmacol; 1992 Jun; 106(2):275-82. PubMed ID: 1393262
[TBL] [Abstract][Full Text] [Related]
16. Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression.
Nishida A; Kobayashi-Uchida A; Akuzawa S; Takinami Y; Shishido T; Kamato T; Ito H; Yamano M; Yuki H; Nagakura Y
Am J Physiol; 1995 Nov; 269(5 Pt 1):G699-705. PubMed ID: 7491961
[TBL] [Abstract][Full Text] [Related]
17. Necessity of intracellular cyclic AMP in inducing gastric acid secretion via muscarinic M3 and cholecystokinin2 receptors on parietal cells in isolated mouse stomach.
Ochi Y; Horie S; Maruyama T; Watanabe K; Yano S
Life Sci; 2005 Sep; 77(16):2040-50. PubMed ID: 15919097
[TBL] [Abstract][Full Text] [Related]
18. Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.
Takemoto Y; Yuki H; Nishida A; Ito H; Kobayashi-Uchida A; Takinami Y; Akuzawa S; Ohta M; Satoh M; Semple G; Miyata K
Arzneimittelforschung; 1998 Apr; 48(4):403-7. PubMed ID: 9608884
[TBL] [Abstract][Full Text] [Related]
19. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
Håkanson R; Ding XQ; Norlén P; Lindström E
Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
[TBL] [Abstract][Full Text] [Related]
20. Fade and tachyphylaxis of gastric acid secretory response to pentagastrin in rat isolated gastric mucosa.
Hirst BH; Holland J; Parsons ME; Price CA
Br J Pharmacol; 1988 Dec; 95(4):1047-56. PubMed ID: 3219480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
